Moderna Stock Slides After CEO Says Current Vaccines Will Struggle Against Omicron

1 month ago 17
PR Distribution

This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn

Updated Nov. 30, 2021 8:33 americium ET / Original Nov. 30, 2021 4:28 americium ET

  • Order Reprints
  • Print Article

Moderna‘s CEO predicted a “material drop” successful the effectiveness of existent vaccines against the Omicron variant and warned it could instrumentality months for cause companies to manufacture the caller jabs astatine scale. Moderna banal was sliding.

Stéphane Bancel said the dispersed of the variant successful South Africa, coupled with the precocious fig of mutations, suggested existing vaccines whitethorn request to beryllium modified adjacent year.


Read Entire Article